Elif A Oral

Biochemistry, Genetics and Molecular BiologyMedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings”.

Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings

Med(2021)10.1016/j.medj.2021.04.001

N/A

1.0DataRank · unranked

28 citations

Angela Subauste, Nevin Ajluni, Nazanene H. Esfandiari, Rasimcan Meral, Adam Neidert +14 more

Endogenous Leptin Concentrations Poorly Predict Metreleptin Response in Patients With Partial Lipodystrophy

The Journal of Clinical Endocrinology & Metabolism(2021)10.1210/clinem/dgab760

N/A

0.796DataRank · unranked

17 citations

Noemi Malandrino, Mary Walter, Adam Neidert, Ranganath Muniyappa, Elif A Oral +2 more

Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy

Diabetes(2022)10.2337/db21-1172

N/A

0.571DataRank · unranked

44 citations

Sara E. Vazquez, Christopher S. Liverman, Mickie Cheng, Zoe Quandt, Andrew F. Kung +22 more

Cardiac phenotype in familial partial lipodystrophy

Clinical Endocrinology(2021)10.1111/cen.14426

N/A

0.510DataRank · unranked

29 citations

Barış Akıncı, André Monteiro da Rocha, Rasimcan Meral, İlgın Yıldırım Şimşir, Süleyman Cem Adıyaman +14 more

Cardiac phenotype in familial partial lipodystrophy

Endocrine Abstracts(2022)10.1530/endoabs.86.ja5

N/A

0DataRank · unranked

0 citations

Barış Akıncı, da Rocha Andre Monteiro, Rasimcan Meral, Simsir Ilgin Yildirim, Adiyaman Suleyman Cem +14 more

Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review

The Journal of Clinical Endocrinology & Metabolism(2023)10.1210/clinem/dgad606

N/A

0DataRank · unranked

24 citations

Maria Cristina Foss‐Freitas, Natália Rossin Guidorizzi, Merve Çelik Güler, Donatella Gilio, Jessica N. Maung +10 more

A Very-Low-Calorie Diet Can Cause Remission of Diabetes Mellitus and Hypertriglyceridemia in Familial Partial Lipodystrophy

Obesity Facts(2023)10.1159/000533992

N/A

0DataRank · unranked

9 citations

Özge Besci, Rasimcan Meral, Adam Neidert, Thomas L. Chenevert, Elif A Oral +2 more

Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy

Diabetes Care(2024)10.2337/dc23-1614

N/A

0DataRank · unranked

29 citations

Salman Imam, Adam Neidert, ANABELA DILL GOMES, David T. Broome, Elif A Oral +1 more

Metabolic and other morbid complications in congenital generalized lipodystrophy type 4

American Journal of Medical Genetics Part A(2024)10.1002/ajmg.a.63533

N/A

0DataRank · unranked

13 citations

Saif Al-Yaarubi, Nivedita Patni, Nadia Alhashmi, Azza Al‐Shidhani, Flavia Prodam +33 more

Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY

Diabetes Care(2024)10.2337/dc24-0730

N/A

0DataRank · unranked

9 citations

Alina Mehdi, Colby Chase, Maria Foss de Freitas, Brigid Gregg, Elif A Oral +2 more

Early B-cell transcription factor-2 defect as a novel cause of lipodystrophy: disruption of the adipose tissue character and integrity

Insula-revista De Letras Y Ciencias Humanas(2024)10.1101/2024.06.24.24309093

N/A

0DataRank · unranked

0 citations

Donatella Gilio, André Monteiro da Rocha, Lynn Pais, Melanie O’Leary, Heidi L. Rehm +7 more

GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series

BMJ Open Diabetes Research & Care(2025)10.1136/bmjdrc-2024-004885

N/A

0DataRank · unranked

6 citations

Lily Deng, Colby Chase, Maria Cristina Foss‐Freitas, Brigid Gregg, Rochelle N. Naylor +5 more

Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?

Diabetes Care(2025)10.2337/dc24-2408

N/A

0DataRank · unranked

6 citations

Merve Çelik Güler, Diarratou Kaba, Jeevitha Prativadi, Eric Frontera, Maria Cristina Foss‐Freitas +7 more

Changes After Leptin Administration in Partial Lipodystrophy and Factors Associated With Hepatic and Metabolic Response

Journal of the Endocrine Society(2025)10.1210/jendso/bvaf067

N/A

0DataRank · unranked

2 citations

Nevin Ajluni, Rasimcan Meral, Adam Neidert, Maria Foss de Freitas, Donatella Gilio +3 more

Altered lipid metabolism and inflammatory programs associate with adipocyte loss in familial partial lipodystrophy 2

Journal of Clinical Investigation(2025)10.1172/jci198387

N/A

0DataRank · unranked

2 citations

Rebecca L. Schill, Akira Nishii, Maria Foss de Freitas, Bonje Obua, Marcus Nygård +24 more

Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Paris, France, 20–21 May 2025

Annales d Endocrinologie(2025)10.1016/j.ando.2025.102432

N/A

0DataRank · unranked

1 citations

David Araújo‐Vilar, Barış Akıncı, Alain R. Thierry, Beaupere Carine, Élise Bismuth +24 more

Use of Dual GIP/GLP-1 RA in HNF1A-MODY and HNF4A-MODY

Deep Blue (University of Michigan)(2025)10.7302/25164

N/A

0DataRank · unranked

0 citations

Alina Mehdi, Colby Chase, Maria Foss de Freitas, Brigid Gregg, Elif A Oral +2 more

The Metabolic Equivalent BMI in Patients with Familial Partial Lipodystrophy (FPLD) Compared with Those with Severe Obesity

Obesity(2021)10.1002/oby.23049

N/A

0DataRank · unranked

17 citations

Maria Cristina Foss‐Freitas, Rasimcan Meral, Muhammet Özer, Abdelwahab Jalal Eldin, Barış Akıncı +4 more

Iron parameters in patients with partial lipodystrophy and impact of exogenous leptin therapy

BMJ Open Diabetes Research & Care(2021)10.1136/bmjdrc-2021-002385

N/A

0DataRank · unranked

0 citations

Sabine Boutros, Benjamin J. Ryan, Pinar Sargin, Barış Akıncı, Adam Neidert +4 more

Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features

Lara D. Veeken(2022)10.1093/rheumatology/keac428

N/A

0DataRank · unranked

4 citations

Rose Graf, Sara Sabbagh, Angeles S. Galindo‐Feria, Iago Pinal‐Fernandez, Katherine Pak +70 more